Dongming Li - Shanghai Pharmaceuticals Vice President

601607 Stock   19.09  0.14  0.73%   

President

Dongming Li is Vice President of Shanghai Pharmaceuticals Holding
Age 56
Phone86 21 6373 0908
Webhttps://www.sphchina.com

Shanghai Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0641 %, meaning that it generated $0.0641 on every $100 dollars invested by stockholders. Shanghai Pharmaceuticals' management efficiency ratios could be used to measure how well Shanghai Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 10 records

PRESIDENT Age

Lan HaiFiberhome Telecommunication Tec
48
Shiyu LiFiberhome Telecommunication Tec
51
Jiansen YuanFiberhome Telecommunication Tec
46
Zhiwen FanFiberhome Telecommunication Tec
44
Lei LiFiberhome Telecommunication Tec
41
Lin OuHengFeng Information Technology
57
Yang WangFiberhome Telecommunication Tec
46
Weicheng XiongFiberhome Telecommunication Tec
43
Zhiqiang FanFiberhome Telecommunication Tec
48
Zeng JunFiberhome Telecommunication Tec
47
Shanghai Pharmaceuticals Holding (601607) is traded on Shanghai Stock Exchange in China and employs 48,164 people.

Management Performance

Shanghai Pharmaceuticals Leadership Team

Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Shuai Shao, Vice President
Qiuhua Yang, Executive Chairman
Ying Ke, Director Center
Tao Zhong, Board VP
Man Cho, Pres Director
Shunjiang Yu, Chief Officer
Bo CPA, CFO and Presidentident
Ming Dong, Executive Director
Dongming Li, Vice President
Yongzhong Li, VP Director
Jinqi Yu, G Mang
Shui ACS, Joint Secretary
Pui Wong, Joint Secretary
Bo Shen, CFO, President
Linqiong Dong, Securities Representative

Shanghai Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shanghai Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.